Low risk does not mean absence of disease: from the cardiovascular score to atherosclerosis demonstrated by imaging

Authors

  • Andrés S Kohan Socio FAC , Hospital de complejidad creciente Dr. René Favaloro, Santa Rosa, La Pampa, Argentina
  • Juan P Corso Hospital de complejidad creciente Dr. René Favaloro, Santa Rosa, La Pampa, Argentina

DOI:

https://doi.org/10.63600/8307xv70

Keywords:

Cardiovascular risk, PREVENT, SCORE2, Atherosclerosis, Coronary calcium, Primary prevention

Abstract

Cardiovascular risk scores are central tools for primary prevention, but they should not be interpreted as diagnostic proof of the absence of atherosclerosis. In young or middle-aged adults, chronological age and the 10-year time horizon may yield low-risk estimates despite significant arterial disease. This discordance becomes clinically relevant when vascular ultrasound, coronary artery calcium scoring, or coronary computed tomography angiography identify an atherosclerotic burden not anticipated by the probabilistic model. We propose integrating estimated risk, clinical-biological modifiers, and targeted vascular imaging to reclassify discordant patients and adjust preventive intensity according to actually demonstrated disease.

Author Biographies

  • Andrés S Kohan, Socio FAC, Hospital de complejidad creciente Dr. René Favaloro, Santa Rosa, La Pampa, Argentina

    Médico cardiólogo, especialista en imágenes cardiovasculares. Fellow en Imágenes Cardiovasculares ICBA. Presidente de la Asociación Pampeana de Cardiología. Jefe de Medicina Vascular y Preventiva en ICARDIO/DIAGNOSIS.

  • Juan P Corso, Hospital de complejidad creciente Dr. René Favaloro, Santa Rosa, La Pampa, Argentina

    Médico cardiólogo, especialista en imágenes cardiovasculares. Maestría en Imágenes Cardiovasculares UNLP. Presidente de la SAC Pampeana de Cardiología. Jefe de Cardiología del Hospital de Complejidad creciente Dr René Favaloro.

References

1. Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations. Circulation. 2024;149:430-449.

2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-3337.

3. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.

4. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72:434-447.

5. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459-2472.

Downloads

Published

2026-09-30

How to Cite

1.
Low risk does not mean absence of disease: from the cardiovascular score to atherosclerosis demonstrated by imaging. Rev. Fed. Arg. Cardiol. [Internet]. 2026 Sep. 30 [cited 2026 Oct. 3];55(3):220-1. Available from: https://revistafac.org.ar/ojs/index.php/revistafac/article/view/860